Compound ID | 483
Class: Quinolone
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | DNA gyrase inhibitors; DNA topoisomerase inhibitors; active against atypical respiratory tract infection |
Institute where first reported: | Procter and Gamble Pharmaceuticals, US |
Year first mentioned: | 2000 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/273122357 |
Citations: |
|